Indeed, the combined treatment of Survivin -a tumor-associated Ag- and rTcCalr inhibited tumor growth of a melanoma cell line expressing Survivin and this was associated with the tumor phagocytosis (Aguilar-Guzmán et al., 2014). Here, BIRC5 is linked to melanoma.